Pancreatic neuroendocrine tumor liver metastasis in a patient with previously diagnosed pancreatic adenocarcinoma: an unexpected diagnosis

Abstract

Locally advanced pancreatic carcinoma has an usually poor prognosis despite multimodal approaches and sequential chemotherapy. The authors present a case of a long-term survivor with stage III pancreatic adenocarcinoma achieving partial response after a multimodal approach including local and systemic treatments. However, three years after diagnosis and amidst several episodes of cholangitis, hepatic metastasis were suspected. Despite pancreatic adenocarcinoma being the obvious culprit for metastization, a hepatic biopsy was considered at that time given a stable primary disease and presenting three years since the initial diagnosis. At this point, a biopsy could have specific diagnostic, prognostic and therapeutic implications and after it was performed, an unexpected diagnosis of pancreatic neuroendocrine tumor was made. Therefore, we urge clinicians to consider hepatic biopsy in similar cases - generally when it may change prognosis and treatment strategies - and perform histological confirmation of metastatic disease whenever feasible, even if the answer may seem obvious at first impression.

Keywords

Neoplasm metastasis / pancreatic cancer / neuroendocrine tumors / biomarkers / survivorship / chemoradiotherapy

References

[1] Ferlay J,Bray F.More deaths from pancreatic cancer than breast cancer in the EU by 2017..Acta Oncol2016;55:1158-60

[2] Yabar CS.Pancreatic cancer..Gastroenterol Clin North Am2016;45:429-45

[3] Balachandran A,Charnsangavej C.Imaging of pancreatic neoplasms..Surg Oncol Clin N Am2014;23:751-88

[4] Ducreux M,Caramella C,Burtin P,Seufferlein T,Van Laethem JL,Arnold D.Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up..Ann Oncol2015;26:v56-68

[5] Young K,Morganstein D,Cunningham D.Pancreatic neuroendocrine tumors: a review..Future Oncol2015;11:853-64

[6] Berardi R.Neuroendocrine tumors: a multidisciplinary approach for a complex disease..J Cancer Metastasis Treat2016;2:277

[7] Riihimäki M,Sundquist K,Hemminki K.The epidemiology of metastases in neuroendocrine tumors: Epidemiology of metastases..Int J Cancer2016;139:2679-86

[8] Oberg K,Kwekkeboom D.Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up..Ann Oncol2012;23:vii124-30

[9] Niikura N,Tokuda Y,Hortobagyi GN.Latest biopsy approach for suspected metastases in patients with breast cancer..Nat Rev Clin Oncol2013;10:711-9

[10] Serafini S,Pozza G,Valmasoni M,Sperti C.Collision of ductal adenocarcinoma and neuroendocrine tumor of the pancreas: a case report and review of the literature..World J Surg Oncol2017;15:93